<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00827736</url>
  </required_header>
  <id_info>
    <org_study_id>00.058</org_study_id>
    <nct_id>NCT00827736</nct_id>
  </id_info>
  <brief_title>Comparison of Treatment Success of Botox Injection in the Internal Sphincter Versus Isosorbidedinitrate Ointment in Patients With an Anal Fissure</brief_title>
  <official_title>Botulin Toxin Versus Isosorbidedinitrate Ointment in Treatment Anal Fissure; A Prospective, Blinded, Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Onze Lieve Vrouwe Gasthuis</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Onze Lieve Vrouwe Gasthuis</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The standard treatment of anal fissure in the netherlands (ISDN ointment) is being compared
      to a relatively new treatment (injection of Botox in the internal anal sphincter). The study
      hypothesis is that after 4 months, Botox has healed more patients than ISDN. The comparison
      is done blinded for the surgeon and the patient.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2002</start_date>
  <completion_date type="Actual">March 2006</completion_date>
  <primary_completion_date type="Actual">March 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>macroscopic healing of the fissure</measure>
    <time_frame>4 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>complications</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fissure recurrence</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fissure related pain</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>costs</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">73</enrollment>
  <condition>Anal Fissure</condition>
  <arm_group>
    <arm_group_label>Botox injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline. In addition, a placebo ointment has to be applied to the anoderm six times a day</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ISDN ointment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>application of ISDN 1% ointment 6 times a day. injection of placebo into internal anal sphincter</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Botox</intervention_name>
    <description>injection of 10U of BT (Botox®; Allergan, Irvine, California, USA) in the IAS on each side of the anterior midline.</description>
    <arm_group_label>Botox injection</arm_group_label>
    <arm_group_label>ISDN ointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ISDN ointment</intervention_name>
    <description>application of ISDN 1% ointment 6 times a day</description>
    <arm_group_label>ISDN ointment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Injection of placebo into internal anal sphincter (ISDN ointment arm)
Applied to the anoderm six times a day (Botox injection arm)</description>
    <arm_group_label>ISDN ointment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all consecutive patients over the age of 18 with a chronic anal fissure presenting to
             our surgical outpatient clinic

        Exclusion Criteria:

          -  pregnancy

          -  previous anal surgery

          -  Crohn's disease

          -  systemic causes of an anal fissure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Gerhards, MD</last_name>
    <role>Study Director</role>
    <affiliation>Onze Lieve Vrouwe Gasthuis</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Onze Lieve Vrouwe Gasthuis</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord Holland</state>
        <zip>1090 HM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <results_reference>
    <citation>Brisinda G, Maria G, Bentivoglio AR, Cassetta E, Gui D, Albanese A. A comparison of injections of botulinum toxin and topical nitroglycerin ointment for the treatment of chronic anal fissure. N Engl J Med. 1999 Jul 8;341(2):65-9. Erratum in: N Engl J Med 1999 Aug 19;341(8):624.</citation>
    <PMID>10395629</PMID>
  </results_reference>
  <verification_date>January 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 20, 2009</study_first_submitted>
  <study_first_submitted_qc>January 22, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 23, 2009</study_first_posted>
  <last_update_submitted>January 22, 2009</last_update_submitted>
  <last_update_submitted_qc>January 22, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 23, 2009</last_update_posted>
  <responsible_party>
    <name_title>S.Festen, MD</name_title>
    <organization>Onze Lieve Vrouwe Gasthuis</organization>
  </responsible_party>
  <keyword>anal fissure</keyword>
  <keyword>fissura ani</keyword>
  <keyword>botox</keyword>
  <keyword>ISDN</keyword>
  <keyword>Nitric oxide donor</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fissure in Ano</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>onabotulinumtoxinA</mesh_term>
    <mesh_term>Botulinum Toxins, Type A</mesh_term>
    <mesh_term>abobotulinumtoxinA</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

